Integrated phenotype–genotype approach in diagnosis and classification of common central nervous system tumours-Reference-Cited by-同舟云学术

Integrated phenotype–genotype approach in diagnosis and classification of common central nervous system tumours

Published:2019-05-16 Issue:3 Volume:75 Page:299-311
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:Histopathology

Author:

Merve Ashirwad¹²³^ORCID,Millner Thomas O¹,Marino Silvia¹

Affiliation:

1. Blizard Institute Barts and the London School of Medicine and Dentistry Queen Mary University of LondonLondon UK

2. Division of Neuropathology UCL Institute of Neurology National Hospital for Neurology and NeurosurgeryLondon UK

3. Department of Histopathology Camelia Botnar Laboratory Great Ormond Street Hospital for Children NHS Foundation Trust London UK

Funder

National Institute for Health Research

Medical Research Council

Brain Tumour Charity

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/his.13849

Reference40 articles.

1. UK CR.Brain other CNS and intracranial tumours incidence statistics: Cancer Research UK;2017[updated January 2018. Data obtained from the Office for National Statistics (July 2017); ISD Scotland (August); Welsh Cancer Intelligence and Surveillance Unit Health Intelligence Division Public Health Wales (October); the Northern Ireland Cancer Registry (July). Data are for UK 5 ICD‐10 C70‐C72 C75.1‐C75.3 D32‐D33 D35.2‐D35.4 D42‐D43 D44.3‐D44.5.]. Available at:http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/brain-other-cns-and-intracranial-tumours/incidence#heading-One. Date accessed 14 January 2019.

2. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

3. The 2007 WHO Classification of Tumours of the Central Nervous System

4. ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the Endocannabinoid System Present in the Glioblastoma Tumour Microenvironment as a Potential Anti-Cancer Strategy;International Journal of Molecular Sciences;2024-01-23

2. Imaging Recommendations for the Diagnosis, Staging, and Management of Adult Brain Tumors;Indian Journal of Medical and Paediatric Oncology;2023-02

3. Epigenetics Analysis Using Artificial Intelligence in the Era of Precision Oncology;Artificial Intelligence and Precision Oncology;2023

4. Glioma extracellular vesicles for precision medicine: prognostic and theragnostic application;Discover Oncology;2022-06-18

5. circRNA derived from CLSPN (circCLSPN) is an oncogene in human glioblastoma multiforme by regulating cell growth, migration and invasion via ceRNA pathway;Journal of Biosciences;2021-07-13